Search Results - "Origoni, M."
-
1
A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study
Published in Climacteric : the journal of the International Menopause Society (01-08-2014)“…Abstract Objective This pilot study aimed to assess the efficacy and feasibility of fractional CO2 laser in the treatment of vulvovaginal atrophy (VVA) in…”
Get full text
Journal Article -
2
Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy
Published in Climacteric : the journal of the International Menopause Society (01-04-2015)“…Abstract Objective To investigate the effects of fractional microablative CO2 laser on sexual function and overall satisfaction with sexual life in…”
Get full text
Journal Article -
3
-
4
Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle
Published in Mucosal immunology (01-11-2013)“…Cervical tissue explants (CTEs) from 22 HIV-1 seronegative women were exposed to R5 HIV-1 ex vivo . Eight CTEs were productively infected in terms of HIV-1 p24…”
Get full text
Journal Article -
5
Extending Human Papillomavirus (HPV) vaccination beyond female adolescents and after treatment for high grade CIN: the Italian HPV Study Group (IHSG) review and position paper
Published in European review for medical and pharmacological sciences (01-08-2020)“…Human PapillomaVirus (HPV) vaccination has been introduced in recent years in clinical practice as the most effective primary prevention strategy for cervical…”
Get more information
Journal Article -
6
Postmenopausal vulvovaginal atrophy (VVA) is positively improved by topical hyaluronic acid application. A prospective, observational study
Published in European review for medical and pharmacological sciences (01-10-2016)“…To evaluate the effectiveness of a topical vaginal preparation containing hyaluronic acid in controlling signs and symptoms correlated with postmenopausal…”
Get more information
Journal Article -
7
Cervical Intraepithelial Neoplasia (CIN) in pregnancy: the state of the art
Published in European review for medical and pharmacological sciences (2014)“…Cervical cancer is the most commonly diagnosed malignancy in pregnancy and cervical screening should be accordingly performed in this particular situation…”
Get more information
Journal Article -
8
Human papillomavirus viral load expressed as relative light units (RLU) correlates with the presence and grade of preneoplastic lesions of the uterine cervix in atypical squamous cells of undetermined significance (ASCUS) cytology
Published in European journal of clinical microbiology & infectious diseases (01-09-2012)“…Human papillomavirus (HPV) testing is more sensitive and has higher negative predictive value (NPV) than the Pap test for the detection of cervical…”
Get full text
Journal Article -
9
"Low-grade positivity" of HPV viral load after atypical squamous cells of undetermined significance (ASC-US) cytology identifies women at low-risk for cervical intraepithelial neoplasia grade 2 and 3
Published in European journal of gynaecological oncology (2012)“…The correlation between high-risk HPV-DNA viral load, expressed as relative light units (RLU) values obtained from the Hybrid Capture 2 (HC2) test, and the…”
Get more information
Journal Article -
10
Splenic hamartoma in pregnancy
Published in Journal of obstetrics and gynaecology (01-02-2012)Get full text
Journal Article -
11
Spontaneous regression of low-grade cervical intraepithelial lesions is positively improved by topical bovine colostrum preparations (GINEDIE®). A multicentre, observational, italian pilot study
Published in European review for medical and pharmacological sciences (2014)“…Human papillomavirus (HPV) is the causal agent of cervical cancer. The great majority of abnormal Pap test results - almost 90% - is referrable to either…”
Get more information
Journal Article -
12
HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice
Published in Ecancermedicalscience (01-01-2012)“…The large amount of literature published over the last two decades on human papillomavirus (HPV)-DNA testing has definitely demonstrated the association…”
Get full text
Journal Article -
13
-
14
Topical testosterone in the treatment of vulvar lichen sclerosus
Published in International journal of gynecology and obstetrics (01-07-1994)“…Comparison between 2% testosterone propionate and petrolatum ointment in the treatment of vulvar lichen sclerosus in a randomized, double-blind, controlled…”
Get more information
Journal Article -
15
Human papillomavirus with co-existing vulvar vestibulitis syndrome and vestibular papillomatosis
Published in International journal of gynecology and obstetrics (01-03-1999)“…Objective: The role of HPV infection in cases of vulvar papillomatosis and vulvar vestibulitis syndrome is still unclear and data from the literature is…”
Get full text
Journal Article -
16
Topical oxatomide: an alternative approach for the treatment of vulvar lichen sclerosus
Published in International journal of gynecology and obstetrics (01-12-1996)“…The treatment of vulvar lichen sclerosus has greatly improved in recent years, with the introduction of new pharmacological approaches and reconsideration of…”
Get more information
Journal Article -
17
Acute isolated tubal torsion in pregnancy due to twisted Morgagni hydatid
Published in Minerva ginecologica (01-02-2008)Get more information
Journal Article -
18
Topical Testosterone in the Treatment of Vulvar Lichen Sclerosus
Published in Obstetrical & gynecological survey (01-03-1995)Get full text
Journal Article -
19
A 12-week treatment with fractional CO 2 laser for vulvovaginal atrophy: a pilot study
Published in Climacteric : the journal of the International Menopause Society (01-08-2014)Get full text
Journal Article -
20
A 12-week treatment with fractional CO^sub 2^ laser for vulvovaginal atrophy: a pilot study
Published in Climacteric : the journal of the International Menopause Society (01-08-2014)“…This pilot study aimed to assess the efficacy and feasibility of fractional CO2 laser in the treatment of vulvovaginal atrophy (VVA) in postmenopausal women…”
Get full text
Journal Article